W STRATEGIES, LLC for ABBOTT LABORATORIES
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 4432: Safe and Accurate Food Labeling Act of 2014. Educated staff about FDA guidances, specifically with respect to glucose meters and certain medical foods. Educated staff about FDA interim final rule dealing with infant formula.Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures).
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Trade (domestic/foreign) TRD
International trade issues related to nutrition.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Taxation/Internal Revenue Code TAX
Monitored legislative efforts to reform the corporate tax system. H.R.4438: American Research and Competitiveness Act of 2014.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Education with respect to implementation issues in the Medicare Competitive Bidding program, specifically as it relates to access to brand name diabetes test strips. Payments issues related to transcatheter mitral valve repair procedures in the Medicare IPPS Final Rule for FY 2015. H.R. 2925: Strengthening Medicare Anti-Fraud Measures Act of 2013.Education about federal regulations related to "anti-switching" rules which prohibit contract suppliers from incentivizing Medicare beneficiaries to switch their current blood glucose monitor.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.